PL375350A1 - Pochodne indolu i ich zastosowanie jako ligandów 5-HT - Google Patents
Pochodne indolu i ich zastosowanie jako ligandów 5-HTInfo
- Publication number
- PL375350A1 PL375350A1 PL03375350A PL37535003A PL375350A1 PL 375350 A1 PL375350 A1 PL 375350A1 PL 03375350 A PL03375350 A PL 03375350A PL 37535003 A PL37535003 A PL 37535003A PL 375350 A1 PL375350 A1 PL 375350A1
- Authority
- PL
- Poland
- Prior art keywords
- ligands
- indol derivatives
- indol
- derivatives
- formula
- Prior art date
Links
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical class C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 title abstract 2
- 239000003446 ligand Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP02027483 | 2002-12-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL375350A1 true PL375350A1 (pl) | 2005-11-28 |
Family
ID=32479712
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL03375350A PL375350A1 (pl) | 2002-12-10 | 2003-11-17 | Pochodne indolu i ich zastosowanie jako ligandów 5-HT |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US7482465B2 (pl) |
| EP (1) | EP1569930B1 (pl) |
| JP (1) | JP4563817B2 (pl) |
| KR (1) | KR20050085472A (pl) |
| CN (1) | CN1723209A (pl) |
| AT (1) | ATE350381T1 (pl) |
| AU (1) | AU2003288077B2 (pl) |
| BR (1) | BR0317126A (pl) |
| CA (1) | CA2509225C (pl) |
| DE (1) | DE60311000T2 (pl) |
| ES (1) | ES2279976T3 (pl) |
| MX (1) | MXPA05006076A (pl) |
| PL (1) | PL375350A1 (pl) |
| WO (1) | WO2004052886A1 (pl) |
| ZA (1) | ZA200505491B (pl) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7371769B2 (en) | 2004-12-07 | 2008-05-13 | Solvay Pharmaceuticals B.V. | Tetrahydropyridin-4-yl indoles with a combination of affinity for dopamine-D2 receptors and serotonin reuptake sites |
| US20060122247A1 (en) | 2004-12-08 | 2006-06-08 | Solvay Pharmaceuticals B.V. | Aryloxyethylamine and phenylpiperazine derivatives with a combination of partial dopamine-D2 receptor agonism and serotonin reuptake inhibition |
| AU2005313390A1 (en) * | 2004-12-08 | 2006-06-15 | Solvay Pharmaceuticals B.V. | Aryloxyethylamine derivatives with a combination of partial dopamine-D2 receptor agonism and serotonin reuptake inhibition |
| EP2771341A4 (en) * | 2011-10-28 | 2015-09-23 | Univ Texas | NEW COMPOSITIONS AND METHOD FOR THE TREATMENT OF CANCER |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8830312D0 (en) | 1988-12-28 | 1989-02-22 | Lundbeck & Co As H | Heterocyclic compounds |
| US5607960A (en) * | 1993-04-22 | 1997-03-04 | Pfizer Inc. | Indole derivatives as 5-HT1-like agonists for use in migraine |
| US6150533A (en) * | 1998-04-08 | 2000-11-21 | American Home Products Corp. | N-aryloxyethyl-indoly-alkylamines for the treatment of depression |
| GB9903784D0 (en) * | 1999-02-18 | 1999-04-14 | Lilly Co Eli | Pharmaceutical compounds |
-
2003
- 2003-11-17 AT AT03779945T patent/ATE350381T1/de not_active IP Right Cessation
- 2003-11-17 CA CA2509225A patent/CA2509225C/en not_active Expired - Fee Related
- 2003-11-17 ES ES03779945T patent/ES2279976T3/es not_active Expired - Lifetime
- 2003-11-17 MX MXPA05006076A patent/MXPA05006076A/es not_active Application Discontinuation
- 2003-11-17 AU AU2003288077A patent/AU2003288077B2/en not_active Ceased
- 2003-11-17 CN CNA2003801053877A patent/CN1723209A/zh active Pending
- 2003-11-17 EP EP03779945A patent/EP1569930B1/en not_active Expired - Lifetime
- 2003-11-17 BR BR0317126-4A patent/BR0317126A/pt not_active Application Discontinuation
- 2003-11-17 JP JP2004557906A patent/JP4563817B2/ja not_active Expired - Fee Related
- 2003-11-17 KR KR1020057010437A patent/KR20050085472A/ko not_active Withdrawn
- 2003-11-17 US US10/538,639 patent/US7482465B2/en not_active Expired - Fee Related
- 2003-11-17 DE DE60311000T patent/DE60311000T2/de not_active Expired - Lifetime
- 2003-11-17 WO PCT/EP2003/012810 patent/WO2004052886A1/en not_active Ceased
- 2003-11-17 PL PL03375350A patent/PL375350A1/pl not_active Application Discontinuation
-
2005
- 2005-07-07 ZA ZA200505491A patent/ZA200505491B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MXPA05006076A (es) | 2005-08-16 |
| ATE350381T1 (de) | 2007-01-15 |
| CN1723209A (zh) | 2006-01-18 |
| ZA200505491B (en) | 2006-05-31 |
| DE60311000T2 (de) | 2007-10-04 |
| DE60311000D1 (de) | 2007-02-15 |
| AU2003288077A1 (en) | 2004-06-30 |
| US7482465B2 (en) | 2009-01-27 |
| WO2004052886A1 (en) | 2004-06-24 |
| AU2003288077B2 (en) | 2010-05-27 |
| JP2006510641A (ja) | 2006-03-30 |
| JP4563817B2 (ja) | 2010-10-13 |
| ES2279976T3 (es) | 2007-09-01 |
| EP1569930B1 (en) | 2007-01-03 |
| CA2509225A1 (en) | 2004-06-24 |
| US20060116405A1 (en) | 2006-06-01 |
| CA2509225C (en) | 2011-09-20 |
| EP1569930A1 (en) | 2005-09-07 |
| BR0317126A (pt) | 2005-10-25 |
| KR20050085472A (ko) | 2005-08-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MXPA05010652A (es) | Pirazoles sustituidos. | |
| PL372926A1 (pl) | Piperydyno-pirydazony i ftalazynony jako inhibitory PDE4 | |
| IL155875A0 (en) | Piperazinylpyrazines compounds as antagonists of serotonin 5-ht2 receptor | |
| TNSN05254A1 (en) | Derivatives of 2-acylamino-4-phenylthiazole, preparation method thereof and application of same in therapeutics | |
| AU2002319814A1 (en) | Substituted 1h-dihydropyrazoles, their preparation and use | |
| GB0130341D0 (en) | Compounds | |
| TW200637853A (en) | Fungicides | |
| MXPA02000973A (es) | Benzofurilpiperazinas y benzofurilhomopiperazinas: agonistas de serotonina. | |
| MXPA02011370A (es) | Iminoazinas substituidas. | |
| IL164509A0 (en) | Furyl compounds | |
| PL1660449T3 (pl) | Pochodne aminopropanolu | |
| MXPA05013149A (es) | Derivados de imidazol como antagonistas del receptor de glutamato. | |
| IL173810A0 (en) | Imidazopyridine derivatives and pharmaceutical compositions containing the same | |
| MXPA05010651A (es) | Compuestos de pirazol. | |
| GB0229081D0 (en) | Multifunctional cationic photoinitiators, their preparation and use | |
| MXPA05005198A (es) | Derivados de imidazoquinolina, como ligandos del receptor a3 de adenosina. | |
| ATE419242T1 (de) | Pyrrolidinylharnstoffderivate als angiogeneseinhibitoren | |
| MXPA06000038A (es) | Pirimidinas 2-sustituidas. | |
| UA83203C2 (uk) | Тіазол-(бі)циклоалкілкарбоксаніліди, засіб на їх основі та застосування для боротьби з небажаними мікроорганізмами | |
| MXPA05010650A (es) | Pirazoles sustituidos. | |
| MXPA06000987A (es) | Derivados de nicotinamida utiles como inhibidores de pde4. | |
| MXPA06003345A (es) | Derivados de aminopiridina como inhibidores de la no-sintasa inducible. | |
| IL188927A0 (en) | Aryloxy quinolines and uses thereof as 5-ht6 modulators | |
| GB0103240D0 (en) | Organic compounds | |
| PL375350A1 (pl) | Pochodne indolu i ich zastosowanie jako ligandów 5-HT |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| REFS | Decisions on refusal to grant patents (taken after the publication of the particulars of the applications) |